Statistical considerations for enumeration of circulating tumor cells

被引:163
作者
Tibbe, Arjan G. J. [1 ]
Miller, M. Craig [1 ]
Terstappen, Leon W. M. M. [1 ]
机构
[1] Immunicon Corp, Huntingdon Valley, PA USA
关键词
rare events; circulating tumor cells; immunomagnetic enrichment;
D O I
10.1002/cyto.a.20369
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Circulating tumor cells (CTCs) in patients with carcinomas are extremely rare. In metastatic breast cancer, the presence of >= 5 CTCs in 7.5 ml of blood has been associated with short survival. As this threshold has clinical implications, it is important to recognize the limitations associated with the detection and enumeration of CTCs. Methods: Statistical analyses were performed on data generated from a multi-center clinical trial that utilized the CellSearch (TM) System to isolate and enumerate CTCs in 7.5 ml blood samples. The statistical issues associated with each step of the process, from blood collection to final image analysis and CTC enumeration, were determined and implemented into a model. Results: A model describing the statistics of the different process steps that are needed for the isolation and detection of CTCs was developed. The model uses the Poisson distribution for blood collection and empirically determined distributions for the isolation and identification of CTCs. The variability between readers was identified as one of the main sources of errors responsible for the current threshold level of five CTCs. Conclusions: Elimination of the errors made in the identification of tumor cells isolated from 7.5 ml of blood could potentially reduce the CTC threshold for the identification of patients with a poor prognosis from the current value of five CTCs to one CTC per 7.5 ml of blood. (c) 2007 International Society for Analytical Cytology.
引用
收藏
页码:154 / 162
页数:9
相关论文
共 18 条
[1]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[2]  
Bajaj S, 2000, CYTOMETRY, V39, P285
[3]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[4]   SAMPLING ERRORS AND THE PRECISION ASSOCIATED WITH COUNTING VERY LOW NUMBERS OF WHITE CELLS IN BLOOD COMPONENTS [J].
DUMONT, LJ .
TRANSFUSION, 1991, 31 (05) :428-432
[5]  
GALLIVAN MVE, 1984, CANCER, V53, P1100, DOI 10.1002/1097-0142(19840301)53:5<1100::AID-CNCR2820530514>3.0.CO
[6]  
2-K
[7]   MODEL STUDY DETECTING BREAST-CANCER CELLS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AT FREQUENCIES AS LOW AS 10(-7) [J].
GROSS, HJ ;
VERWER, B ;
HOUCK, D ;
HOFFMAN, RA ;
RECKTENWALD, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :537-541
[8]  
Kagan M, 2002, J CLIN LIGAND ASSAY, V25, P104
[9]  
KAGAN M, 2002, TUMOR MARKERS PHYSL, P495
[10]  
MYEROWITZ RL, 1977, CANCER, V40, P3107, DOI 10.1002/1097-0142(197712)40:6<3107::AID-CNCR2820400653>3.0.CO